Top stock upgrades today in the BUZZ

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  09 Mar 2026
 

$COIN Coinbase drew renewed interest after commentary suggesting the stock may finally represent a compelling entry point following prolonged volatility in the crypto sector. The shares changed hands near $199.79 while analysts highlighted a potential price target of $343.83, implying more than 70% upside if digital asset activity reaccelerates. The argument behind the optimism centers on Coinbase positioning as the primary regulated gateway for institutional crypto flows. Trading volumes remain below historical peaks, but any sustained recovery in digital asset markets could quickly translate into operating leverage for the platform.

$GEV GE Vernova received a double upgrade from Redburn, reflecting stronger demand expectations for gas turbines as energy systems transition toward hybrid grids that balance renewables with reliable generation capacity. The stock jumped more than 5% to around $830.10 following the call. Analysts see limited upside to the formal target of $844.92, yet the upgrade highlights a structural shift in global power markets where gas turbines remain critical for grid stability during the renewable transition. The market appears to be gradually re-rating the company as an infrastructure enabler rather than a cyclical industrial name.

$JEF Jefferies found itself in the spotlight after Morgan Stanley issued a downgrade citing ongoing legal and credit-related risks. Interestingly, the firm still projects potential upside of more than 50% to a target near $57.84, even as the rating was reduced. Shares traded around $38.16 with relatively strong volume. The mixed message underscores a key tension in the investment bank outlook: operational momentum remains solid, but macro-sensitive businesses such as capital markets and leveraged finance continue to face an uncertain credit environment.

$NVO Novo Nordisk was upgraded by Morgan Stanley from Underweight to Equal Weight following a sharp selloff that materially reset valuation expectations. Shares climbed to about $39.78 while analysts lifted their target to $63.27, implying roughly 59% upside from current levels. The upgrade reflects a reassessment of how aggressively the market discounted growth risks in the obesity drug segment. Demand for GLP-1 therapies remains structurally strong, and the firm appears to believe the earlier correction overshot the fundamental slowdown narrative.

$TFC Truist Financial drew attention after analysts turned more constructive on the banking sector outlook, reflecting improving credit conditions and a stabilizing rate environment. Shares traded around $46.75 with modest gains as traders evaluated how regional banks might benefit from normalization in lending spreads. While the price target data remains incomplete, the upgrade signals a shift toward cautious optimism in financials after a prolonged period of regulatory scrutiny and balance sheet stress across the sector.

$TGT Target received a reaffirmed Buy rating from Argus alongside a price target increase to $145. With shares around $120.14, the implied upside sits near 4%, suggesting analysts see steady improvement rather than a dramatic rerating. The investment thesis revolves around operational discipline and margin recovery under new leadership as the company continues to navigate a competitive retail environment and shifting consumer spending patterns.

$TSLA Tesla continues to generate heavy trading activity as public commentary involving CEO Elon Musk sparked renewed debate across social media and investor circles. Shares traded near $398.68 with a target around $439 implying roughly 10% upside. Despite the headline noise, the core investment narrative remains tied to the progress in scaling autonomous technology, energy storage, and software-driven vehicle capabilities. Analysts appear focused less on the headlines and more on long-term platform economics.

$WBD Warner Bros. Discovery traded near $27.75 as analysts assessed the mixed reception of its latest major theatrical release. The company still carries a price target around $38.51, suggesting potential upside of nearly 39% if film performance and streaming engagement stabilize. Investors remain divided between near-term box office volatility and the longer-term thesis that content libraries and distribution platforms provide durable strategic value.

View All Headlines